Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
DDDr. Dereck Mush, MD, MBA
Jul 30
What they do
The company creates virtually painless, skin-attached blood sampling devices for self-collection. Pharmaceutical companies, clinical research organizations, and healthcare systems buy these devices to enable remote patient monitoring and decentralized clinical trials.
The record
- Vertical
- Medical Devices
- Sub-segment
- Point of care diagnostics
- Product type
- Device
- Stage
- Series B
- Headquarters
- Seattle, USA
- Region
- North America
- Founded
- 2011
- Total funding
- $83M raised
Notable investors: RA Capital Management, Foresite Capital, Techstars.
Also in Medical Devices
Related on The Signal
The AI ECG Cardiology Market After Queen of Hearts: Who the De Novo Clearance Actually Benefits
DDDr. Dereck Mush, MD, MBA
Sep 17
The Digital Health Valuation Reset: How Sword Health's Acquisition of Headspace Redefines Enterprise Whole-Person Care
DDDr. Dereck Mush, MD, MBA
Sep 14
Health Systems Are Buying Fewer Vendors. That Is the Whole Market Story of 2026.
DDDr. Dereck Mush, MD, MBA
Aug 19